医师说这是“甲状腺突眼症”。
综合病史、体格检查及化验检查结果分析,临床诊断考虑为突眼性甲状腺毒症。
Analysis of the medical history in association with the positive physical and laboratory findings suggested a clinical diagnosis of exophthalmia thyrotoxicosis.
在接受抗甲状腺药物(atd)治疗的突眼性甲状腺肿615例患者中,215例(34.9%)发生毒性反应。
Out of 615 patients with Graves' disease who accepted the treatment of antithyroid drugs (ATD), 215 (34.9%) developed toxic effects of the drugs.
应用推荐